Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Worm Enzyme Has Promise for Patients with Cardiovascular Disease

12.12.2002


The simple worm has at least one talent that could benefit most Americans.




It can convert Omega-6 -- a group of fatty acids abundant in the Western diet with the potential to promote inflammation - into Omega-3, another class of fatty acids that decreases inflammation, helping keep vessel walls smooth and blood free-flowing.

The question one Medical College of Georgia researcher is asking is whether the enzyme these C. Elegans, or nematodes, use can work the same magic in people.


Dr. Steffen E. Meiler and his colleagues at Massachusetts General Hospital and Harvard Medical School have found, at least in laboratory studies of human endothelial cells, that this enzyme, fat-1, can halve the number of white blood cells that can adhere to the surface of blood vessel walls, laying a foundation for vascular disaster.

Dr. Meiler, an anesthesiologist and critical care specialist, got interested in the process that turns blood vessel linings from Teflon to Velcro because of the increased incidence of heart attack, stroke and deadly heart rhythms following surgery in patients with known cardiovascular disease.

The last decade of science has provided solid evidence that inflammation plays a role in cardiovascular disease in general; Dr. Meiler believes inflammation may also be the culprit that puts some people at risk following surgery.

"Our working hypothesis is that the vascular endothelium becomes activated or inflamed after surgery and begins to react with blood components, such as white blood cells, setting the stage for high-risk cardiac complications, such as a heart attack,” said Dr. Meiler, vice chairman for research for the MCG Department of Anesthesiology and Perioperative Medicine. "Something about anesthesia and surgery and the type of morbidity that these patients bring makes this happen acutely. And right now there is no way we can protect the endothelium in the perioperative window."

But what he and his colleagues are finding may one day provide that protection.

Their work, funded by the National Institutes of Health, was selected for the American Heart Association’s Best of Scientific Sessions 2002, honoring the top scientific studies presented at the association’s Nov. 17-20 annual meeting.

Cardiologists already recommend more Omega-3 - found in high concentrations in fish such as salmon, mackerel and tuna - in the diet, through supplements or both. But most Americans likely consume far more Omega-6, found in high levels in foods such as beef, margarine, mayonnaise and vegetable oils. Native Alaskans, with fish-rich diets and low rates of cardiovascular disease, are good examples of the vessel-protecting potential of the Omega-3 polyunsaturated fatty acids.

Abundant evidence accumulated in animal and clinical studies shows that Omega-3 protects vessels by exerting an anti-inflammatory effect; it’s also a powerful anti-arrhythmic. In fact, it’s also been shown beneficial in inflammatory diseases such as rheumatoid arthritis and inflammatory bowel disease.

Inflammation, part of the body’s natural response to injury, appears to have a fairly early role in cardiovascular disease. Fatty streaks in the vessels are often the earliest signs of disease that may one day mature into vessel-narrowing plaque, a nasty concoction of monocytes, lymphocytes, cholesterol, lipids, debris, excess smooth muscle cells and more.

"Inflammation probably sets in at the time when early streaking starts," Dr. Meiler said, probably because the early fat deposits evoke that response. But in cardiovascular disease, inflammation goes unchecked and becomes self-promoting. The Teflon-like endothelial lining of the blood vessels express adhesion molecules that create a sticky trap for white blood cells floating by in the bloodstream. The ones that stick can then migrate into the vessel wall to do their inflaming work.

"What is known is that blood vessels that are exposed to high cholesterol and that already have developed a certain stage of arteriosclerosis will already be pre-inflamed," Dr. Meiler said. "These cells are not normal. It is our hypothesis that when you add surgery in these folks, these cells will respond particularly vigorously and develop an endothelial inflammatory phenotype that will then cause more interaction with white blood cells and may lead to myocardial infarction."

That’s where the worms come in.

Worms need a lot of Omega-3 to develop and, in contrast to humans and other mammals, they can convert Omega-6 to Omega-3, using the fatty acid desaturase fat-1.

So the scientists took the fat-1 enzyme and, using a virus as a delivery mechanism, put it into human endothelial cells, then added Omega-6 and stimulated the inflammatory process. They found, at least in culture, that the worm enzyme could convert Omega-6 fatty acids to their protective Omega-3 counterparts in human vascular endothelial cells as well.

Then the researchers wanted to look specifically at the level of inflammation as evidenced by the endothelium being transform from smooth to sticky. They looked at three surface-adhesion molecules important in trapping white blood cells and, again, fat-1 dramatically reduced these inflammatory markers on the surface of the human endothelium.

Next, just to make sure that this reduced level of adhesion molecule expression translated to fewer white blood cells sticking to the walls, they mimicked what goes on inside the vessels by putting the endothelial cells in a chamber with monocyte-rich fluid flowing over them. That’s when they noted the 50 percent reduction in sticking of these cells that cause much of the inflammatory damage.

The next step is to develop a transgenic mouse that expresses fat-1 and see if the findings translate to a whole organism.

"The overriding question is how acute endothelial inflammation affects perioperative management," he said. Whether a genetic approach, as taken by Dr. Meiler and his colleagues, to change the lipid profile of human endothelial cells will ever become a practical consideration, remains to be seen.

However, “Our results have stirred a lot of excitement and we are eager to continue our work in this area,” Dr. Meiler said.

Toni Baker | EurekAlert!
Further information:
http://www.mcg.edu/news/2002NewsRel/Meiler.html
http://www.mcg.edu/

More articles from Health and Medicine:

nachricht On track to heal leukaemia
18.01.2017 | Universitätsspital Bern

nachricht Penn vet research identifies new target for taming Ebola
12.01.2017 | University of Pennsylvania

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: How gut bacteria can make us ill

HZI researchers decipher infection mechanisms of Yersinia and immune responses of the host

Yersiniae cause severe intestinal infections. Studies using Yersinia pseudotuberculosis as a model organism aim to elucidate the infection mechanisms of these...

Im Focus: Interfacial Superconductivity: Magnetic and superconducting order revealed simultaneously

Researchers from the University of Hamburg in Germany, in collaboration with colleagues from the University of Aarhus in Denmark, have synthesized a new superconducting material by growing a few layers of an antiferromagnetic transition-metal chalcogenide on a bismuth-based topological insulator, both being non-superconducting materials.

While superconductivity and magnetism are generally believed to be mutually exclusive, surprisingly, in this new material, superconducting correlations...

Im Focus: Studying fundamental particles in materials

Laser-driving of semimetals allows creating novel quasiparticle states within condensed matter systems and switching between different states on ultrafast time scales

Studying properties of fundamental particles in condensed matter systems is a promising approach to quantum field theory. Quasiparticles offer the opportunity...

Im Focus: Designing Architecture with Solar Building Envelopes

Among the general public, solar thermal energy is currently associated with dark blue, rectangular collectors on building roofs. Technologies are needed for aesthetically high quality architecture which offer the architect more room for manoeuvre when it comes to low- and plus-energy buildings. With the “ArKol” project, researchers at Fraunhofer ISE together with partners are currently developing two façade collectors for solar thermal energy generation, which permit a high degree of design flexibility: a strip collector for opaque façade sections and a solar thermal blind for transparent sections. The current state of the two developments will be presented at the BAU 2017 trade fair.

As part of the “ArKol – development of architecturally highly integrated façade collectors with heat pipes” project, Fraunhofer ISE together with its partners...

Im Focus: How to inflate a hardened concrete shell with a weight of 80 t

At TU Wien, an alternative for resource intensive formwork for the construction of concrete domes was developed. It is now used in a test dome for the Austrian Federal Railways Infrastructure (ÖBB Infrastruktur).

Concrete shells are efficient structures, but not very resource efficient. The formwork for the construction of concrete domes alone requires a high amount of...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

12V, 48V, high-voltage – trends in E/E automotive architecture

10.01.2017 | Event News

2nd Conference on Non-Textual Information on 10 and 11 May 2017 in Hannover

09.01.2017 | Event News

Nothing will happen without batteries making it happen!

05.01.2017 | Event News

 
Latest News

A big nano boost for solar cells

18.01.2017 | Power and Electrical Engineering

Glass's off-kilter harmonies

18.01.2017 | Materials Sciences

Toward a 'smart' patch that automatically delivers insulin when needed

18.01.2017 | Life Sciences

VideoLinks
B2B-VideoLinks
More VideoLinks >>>